Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • For Subscribers
    • For Advertisers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • For Subscribers
    • For Advertisers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

June 01, 1991; Volume 39,Issue 6
  • You have access
    Influence of recombinant gamma-aminobutyric acid-A receptor subunit composition on the action of allosteric modulators of gamma-aminobutyric acid-gated Cl- currents.
    G Puia, S Vicini, P H Seeburg and E Costa
    Molecular Pharmacology June 1991, 39 (6) 691-696;
  • You have access
    Activation of the c-jun protooncogene in human myeloid leukemia cells treated with etoposide.
    E Rubin, S Kharbanda, H Gunji and D Kufe
    Molecular Pharmacology June 1991, 39 (6) 697-701;
  • You have access
    Expression and characterization of the long and short splice variants of GS alpha in S49 cyc- cells.
    J K O'Donnell, R W Sweet and J M Stadel
    Molecular Pharmacology June 1991, 39 (6) 702-710;
  • You have access
    Phosphodiesterase II, the cGMP-activatable cyclic nucleotide phosphodiesterase, regulates cyclic AMP metabolism in PC12 cells.
    M E Whalin, J G Scammell, S J Strada and W J Thompson
    Molecular Pharmacology June 1991, 39 (6) 711-717;
  • You have access
    Mechanism of antiviral and cytotoxic action of (+/-)-6' beta-fluoroaristeromycin, a potent inhibitor of S-adenosylhomocysteine hydrolase.
    M Cools, J Balzarini and E De Clercq
    Molecular Pharmacology June 1991, 39 (6) 718-724;
  • You have access
    Central benzodiazepine receptors: in vitro efficacies and potencies of 3-substituted 1,4-benzodiazepine stereoisomers.
    G Maksay, Z Tegyey and M Simonyi
    Molecular Pharmacology June 1991, 39 (6) 725-732;
  • You have access
    Pivotal role for aspartate-80 in the regulation of dopamine D2 receptor affinity for drugs and inhibition of adenylyl cyclase.
    K A Neve, B A Cox, R A Henningsen, A Spanoyannis and R L Neve
    Molecular Pharmacology June 1991, 39 (6) 733-739;
  • You have access
    Potent Gi-mediated inhibition of adenylyl cyclase by a phosphonate analog of monooleylphosphatidate.
    M A Proll and R B Clark
    Molecular Pharmacology June 1991, 39 (6) 740-744;
  • You have access
    Role for ionotropic and metabotropic receptors in quisqualate-stimulated inositol polyphosphate accumulation in rat cerebral cortex.
    J G Baird, R A Challiss and S R Nahorski
    Molecular Pharmacology June 1991, 39 (6) 745-753;
  • You have access
    Synthetic phosphorothioate-containing analogues of inositol 1,4,5-trisphosphate mobilize intracellular Ca2+ stores and interact differentially with inositol 1,4,5-trisphosphate 5-phosphatase and 3-kinase.
    S T Safrany, R J Wojcikiewicz, J Strupish, J McBain, A M Cooke, B V Potter and S R Nahorski
    Molecular Pharmacology June 1991, 39 (6) 754-761;
  • You have access
    Calcium signaling and secretory responses in endothelin-stimulated anterior pituitary cells.
    S S Stojilković, T Iida, F Merelli and K J Catt
    Molecular Pharmacology June 1991, 39 (6) 762-770;
  • You have access
    Kinetic analysis of ligand binding to the Ehrlich cell nucleoside transporter: pharmacological characterization of allosteric interactions with the [3H]nitrobenzylthioinosine binding site.
    J R Hammond
    Molecular Pharmacology June 1991, 39 (6) 771-779;
  • You have access
    Intrinsic activity of enantiomers of 8-hydroxy-2-(di-n-propylamino)tetralin and its analogs at 5-hydroxytryptamine1A receptors that are negatively coupled to adenylate cyclase.
    L J Cornfield, G Lambert, L E Arvidsson, C Mellin, J Vallgårda, U Hacksell and D L Nelson
    Molecular Pharmacology June 1991, 39 (6) 780-787;
  • You have access
    Wheat germ agglutinin potentiates specific binding of platelet-activating factor to human platelet membranes and induces platelet-activating factor synthesis in intact platelets.
    S B Hwang and S Wang
    Molecular Pharmacology June 1991, 39 (6) 788-797;
  • You have access
    Multiple affinity forms of the calcitonin gene-related peptide receptor in rat cerebellum.
    T K Chatterjee and R A Fisher
    Molecular Pharmacology June 1991, 39 (6) 798-804;
  • You have access
    Highly potent and selective inhibition of human immunodeficiency virus type 1 by a novel series of 6-substituted acyclouridine derivatives.
    M Baba, E De Clercq, H Tanaka, M Ubasawa, H Takashima, K Sekiya, I Nitta, K Umezu, R T Walker and S Mori
    Molecular Pharmacology June 1991, 39 (6) 805-810;
  • You have access
    Difference in the susceptibility of two phenobarbital-inducible forms, P450IIB1 and P450IIB2, to thyroid hormone- and growth hormone-induced suppression in rat liver: phenobarbital-inducible P450IIB2 suppression by thyroid hormone acting directly, but not through the pituitary system.
    N Murayama, M Shimada, Y Yamazoe and R Kato
    Molecular Pharmacology June 1991, 39 (6) 811-817;
  • You have access
    Potent in vitro anti-human immunodeficiency virus-1 activity of modified human serum albumins.
    R W Jansen, G Molema, R Pauwels, D Schols, E De Clercq and D K Meijer
    Molecular Pharmacology June 1991, 39 (6) 818-823;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 39, Issue 6
1 Jun 1991
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Read
Loading
  • How Many G Protein-Coupled Receptors are Drug Targets?
  • Histamine H3 Receptor
  • Histamine Receptor Pharmacology
  • Biased Agonism in Drug Discovery
  • Serum Stabilization of the VEGFR-2 Antagonist RLYE
More...
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2019 by the American Society for Pharmacology and Experimental Therapeutics